Invasive Fungal Disease
20
5
5
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 20 trials
100.0%
+13.5% vs benchmark
25%
5 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (20)
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
De-escalation - Antifungal Treatment Immunocompromised Patients
Immunomonitoring of Mold Invasive Infections
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD( Breakthrough Invasive Fungal Disease) in Patients With Malignant Hematological Diseases
Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi
L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis
Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD
Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients
A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease
FungiScope - A Global Emerging Fungal Infection Registry
To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD
LFD of Aspergillus Antigen in Paediatrics
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China
Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation